Adaptive Biotechnologies Corp
ADPTNasdaqCIK 1478320HealthcareFiscal year ends Dec 31
All transactions: 9
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-26 | Rubinstein JuliePresident and COO, Officer | Sale | 3,378 | $26.30 | $88.8k | Form 4 |
| 2026-10-26 | Rubinstein JuliePresident and COO, Officer | Sale | 8,503 | $25.94 | $220.6k | Form 4 |
| 2026-10-26 | Rubinstein JuliePresident and COO, Officer | Option exercise | 11,881 | $12.14 | $144.2k | Form 4 |
| 2026-10-23 | Rubinstein JuliePresident and COO, Officer | Sale | 7,381 | $25.28 | $186.6k | Form 4 |
| 2026-10-23 | Rubinstein JuliePresident and COO, Officer | Sale | 4,500 | $24.50 | $110.3k | Form 4 |
| 2026-10-23 | Rubinstein JuliePresident and COO, Officer | Option exercise | 11,881 | $12.14 | $144.2k | Form 4 |
| 2026-10-22 | Rubinstein JuliePresident and COO, Officer | Sale | 1,700 | $25.29 | $43.0k | Form 4 |
| 2026-10-22 | Rubinstein JuliePresident and COO, Officer | Sale | 10,181 | $24.38 | $248.2k | Form 4 |
| 2026-10-22 | Rubinstein JuliePresident and COO, Officer | Option exercise | 11,881 | $12.14 | $144.2k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 29, 2026, 19:53 ET. Listed shows no prices and gives no investment advice.